Meningococcal conjugate vaccines: New opportunities and new challenges

Lancet

Volumn 354, Issue 9179, 1999, Pages 615-616

  Maiden, Martin C J ^a   Spratt, Brian G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE;

ADOLESCENT; BACTERIAL MEMBRANE; DRUG POTENCY; HEALTH SURVEY; HUMAN; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NOTE; PATHOGENICITY; PRIORITY JOURNAL; SEROPREVALENCE; STRAIN DIFFERENCE; UNITED KINGDOM; VACCINATION;

EID: 0033592235     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)00252-4     Document Type: Note

References (16)

1. MacDonald N.E., Halperin S.A., Law B.J., Forrest B., Danzig L.E., Granoff D.M. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial. JAMA. 280:1998;1685-1689.
2. Stephens D.S. Uncloaking the meningococcus: dynamics of carriage and disease. Lancet. 353:1999;941-942.
3. Maiden M.C.J., Feavers I.M. Population genetics and global epidemiology of the human pathogen Neisseria meningitidis. Baumberg S., Young J.P.W., Wellington E.M.H., Saunders J.R.et al. Population genetics of bacteria. 1995;269-293 Cambridge University Press, Cambridge.
4. Vedros N.A. Development of meningococcal serogroups. Vedros N.A. Evolution of meningococcal disease. 1987;33-37 Cambridge University Press, Boca Raton, FL.
5. Racoosin J.A., Whitney C.G., Conover C.S., Diaz P.S. Serogroup Y meningococcal disease in Chicago, 1991-1997. JAMA. 280:1998;2094-2098.
6. Maiden M.C.J., Bygraves J.A., Feil E.et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA. 95:1998;3140-3145.
7. Caugant D.A., Kristiansen B.E., Froholm L.O., Bovre K., Selander R.K. Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers. Infect Immun. 56:1988;2060-2068.
8. Wang J.F., Caugant D.A., Morelli G., Koumaré B., Achtman M. Antigenic and epidemiological properties of the ET-37 complex of Neisseria meningitidis. J Infect Dis. 167:1993;1320-1329.
9. Vogel U., Morelli G., Zurth K.et al. Necessity of molecular techniques to distinguish between Neisseria meningitidis strains isolated from patients with meningococcal disease and from their healthy contacts. J Clin Microbiol. 36:1998;2465-2470.
10. Raymond N.J., Reeves M., Ajello G.et al. Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease. J Infect Dis. 176:1997;1277-1284.
11. Takala A.K., Santosham M., Almeido-Hill J.et al. Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr Infect Dis J. 12:1993;593-599.
12. Slack M.P., Azzopardi H.J., Hargreaves R.M., Ramsay M.E. Enhanced surveillance of invasive Haemophilus influenzae disease in England, 1990 to 1996: impact of conjugate vaccines. Pediatr Infect Dis J. 7:1998;204-207.
13. Lipsitch M. Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis. 5:1999;336-345.
14. Gupta S., Galvani A. The effects of host heterogeneity on pathogen population structure. Philos Trans R Soc Lond B Biol Sci. 354:1999;711-719.
15. Kwara A., Adegbola R.A., Corrah P.T.et al. Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Trop Med Int Health. 3:1998;742-746.
16. Obaro S.K., Adegbola R.A., Banya W.A., Greenwood B.M. Carriage of pneumococci after pneumococcal vaccination. Lancet. 348:1996;271-272.